Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 378
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 

    Article Cited by others

REVIEW ARTICLE

A short review on structure and role of cyclic-3',5'-adenosine monophosphate-specific phosphodiesterase 4 as a treatment tool

Eskandari Nahid, Mirmosayyeb Omid, Bordbari Gazaleh, Bastan Reza, Yousefi Zahra, Andalib Alireza

Year : 2015| Volume: 4| Issue : 4 | Page no: 175-181

   This article has been cited by
 
1 Inhibitors of phosphodiesterase as cancer therapeutics
Ting Peng,Jun Gong,Yongzhe Jin,Yanping Zhou,Rongsheng Tong,Xin We,Lan bai,Jianyou Shi
European Journal of Medicinal Chemistry. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Roflumilast, type 4 phosphodiesterase inhibitor, attenuates inflammation in rats with ulcerative colitis via down-regulation of iNOS and elevation of cAMP
Nahla E. El-Ashmawy,Naglaa F. Khedr,Hoda A. El-Bahrawy,Samar A. El-Adawy
International Immunopharmacology. 2018; 56: 36
[Pubmed]  [Google Scholar] [DOI]
3 Effects of pentoxifylline on inflammatory markers and blood pressure
Daniel Brie,Amirhossein Sahebkar,Peter E. Penson,Madalina Dinca,Sorin Ursoniu,Maria-Corina Serban,Alberto Zanchetti,George Howard,Ali Ahmed,Wilbert S. Aronow,Paul Muntner,Gregory Y.H. Lip,Nathan D. Wong,Jacek Rysz,Maciej Banach
Journal of Hypertension. 2016; 34(12): 2318
[Pubmed]  [Google Scholar] [DOI]
4 Inhibidores selectivos de fosfodiesterasas, una nueva opción terapéutica en inflamación y autoinmunidad
Diana Hernández-Flórez,Lara Valor
Reumatología Clínica. 2016;
[Pubmed]  [Google Scholar] [DOI]
5 Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity
Diana Hernández-Flórez,Lara Valor
Reumatología Clínica (English Edition). 2016; 12(6): 303
[Pubmed]  [Google Scholar] [DOI]

 

Read this article